Author
Listed:
- Uwe Schlomann
(King’s College London, Institute for Pharmaceutical Science and KCLDI
Marburg University, , Baldingerstrasse, 35033 Marburg, Germany)
- Garrit Koller
(King’s College London, Institute for Pharmaceutical Science and KCLDI)
- Catharina Conrad
(Marburg University, , Baldingerstrasse, 35033 Marburg, Germany)
- Taheera Ferdous
(King’s College London, Institute for Pharmaceutical Science and KCLDI)
- Panagiota Golfi
(King’s College London, Institute for Pharmaceutical Science and KCLDI)
- Adolfo Molejon Garcia
(King’s College London, Institute for Pharmaceutical Science and KCLDI)
- Sabrina Höfling
(King’s College London, Institute for Pharmaceutical Science and KCLDI)
- Maddy Parsons
(King’s College London, Randall Institute)
- Patricia Costa
(Institute of Cancer and Inflammation, St Mary’s School of Medicine, John Vane Building, Charterhouse Square)
- Robin Soper
(Institute of Cancer and Inflammation, St Mary’s School of Medicine, John Vane Building, Charterhouse Square)
- Maud Bossard
(Institute of Cancer and Inflammation, St Mary’s School of Medicine, John Vane Building, Charterhouse Square)
- Thorsten Hagemann
(Institute of Cancer and Inflammation, St Mary’s School of Medicine, John Vane Building, Charterhouse Square)
- Rozita Roshani
(Institute of Cancer and Inflammation, St Mary’s School of Medicine, John Vane Building, Charterhouse Square)
- Norbert Sewald
(Bielefeld University)
- Randal R. Ketchem
(Therapeutic Discovery, AMGEN Inc.)
- Marcia L. Moss
(Biozyme Inc.)
- Fred H. Rasmussen
(Biozyme Inc.)
- Miles A. Miller
(Massachusetts Institute of Technology)
- Douglas A. Lauffenburger
(Massachusetts Institute of Technology)
- David A. Tuveson
(Cold Spring Harbor Laboratory)
- Christopher Nimsky
(Marburg University, , Baldingerstrasse, 35033 Marburg, Germany)
- Jörg W. Bartsch
(King’s College London, Institute for Pharmaceutical Science and KCLDI
Marburg University, , Baldingerstrasse, 35033 Marburg, Germany)
Abstract
Pancreatic ductal adenocarcinoma (PDAC) has a grim prognosis with
Suggested Citation
Uwe Schlomann & Garrit Koller & Catharina Conrad & Taheera Ferdous & Panagiota Golfi & Adolfo Molejon Garcia & Sabrina Höfling & Maddy Parsons & Patricia Costa & Robin Soper & Maud Bossard & Thorsten , 2015.
"ADAM8 as a drug target in pancreatic cancer,"
Nature Communications, Nature, vol. 6(1), pages 1-16, May.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7175
DOI: 10.1038/ncomms7175
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms7175. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.